Conference abstractPublished 28 Feb 2022

HIPPO-YAP1: New Pathway for Cancer Therapy

Authors: Iris Valtingojer

Journal of Psychology and Brain Studies

Volume 6 · Issue 2 · Pages 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The HIPPO signaling pathway is an evolutionary conserved pathway that has received increasing attention in cancer research over the past years. The deregulation of HIPPO kinase signaling and the subsequent activation of the YAP1 transcriptional regulator drives tumor cell proliferation, protects from therapy by promoting cell survival and signals towards a tumor permissive immune environment. In this presentation, I will speak about how to detect YAP1 activation and will present examples of tumors with high YAP1 activity and deregulated HIPPO kinase signaling. I will further give you an overview on strategies for targeting the HIPPO-YAP1 pathway in cancer therapy, including recent advancements on small molecule allosteric ligands of TEAD proteins, which are the preferred transcription factor binding partners of YAP1 and represent the most terminal effectors of the HIPPO-YAP1 signaling cascade.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Psychology and Brain Studies.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Psychology and Brain Studies
  • SubjectMental Health and Psychology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Iris Valtingojer”